The transaction is sourced from an 8-K filing with the SEC, filed via SEC EDGAR and published on April 3, 2025. The deal's current status is pending regulatory approval.
On the financial advisory side, Cantor Fitzgerald & Co. served as financial advisor to Thrive SPC, the target, in a lead capacity. Edge Healthcare Partners served as financial advisor to Aveanna, the acquirer, also in a lead capacity, with the source material pairing each advisor with its respective legal counsel.
On the legal side, Ropes & Gray LLP served as legal advisor to Thrive SPC, the target, while Bass, Berry & Sims provided legal counsel to Aveanna, the acquirer.
Beyond the cash and stock consideration structure noted in the deal subtype, with a disclosed value of $75,000,000, no further detail on the specific split between cash and stock components, or other structural terms, is provided in the facts block.
Several items are not disclosed in the available record. The precise cash-versus-stock consideration mix is not broken out beyond the general subtype classification, and no expected closing date or further timeline detail beyond the April 2025 filing date and pending-regulatory status is given.